Tianhua Yan
Nanjing, 210009, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Liquiritin in Chaihu-shugan-san alleviates Parkinson's Disease via PPARα-mediated inhibition of SCD1/FADS2-dependent Ferroptosis.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: April 17, 2025
Integrated network pharmacology, bioinformatics, and experiment analysis to decipher the molecular mechanism of Salidroside on Gastric cancer via targeting NCOA4-mediated ferritinophagy.
Journal: Chemico-biological interactions
Published: November 20, 2024
Cysteine-S-sulfate promotes arteriosclerosis obliterans by inducing TH17 differentiation and promoting pyroptosis.
Journal: International immunopharmacology
Published: October 21, 2024
Identification of preventive biomarkers associated with circadian rhythms in traumatic brain injury-mediated depression: Expression of SERPINE1 protein and bioinformatics analysis.
Journal: International journal of biological macromolecules
Published: October 17, 2024
To elucidate the effect of Ruanjian Qingmai granules on arteriosclerosis obliterans from the perspective of cholesterol efflux.
Journal: Frontiers in medicine
Published: October 14, 2024
Exploring the Kidney-Brain Crosstalk: Biomarkers for Early Detection of Kidney Injury-Related Alzheimer's Disease.
Journal: Journal of inflammation research
Published: October 05, 2024
Salidroside sensitizes Triple-negative breast cancer to ferroptosis by SCD1-mediated lipogenesis and NCOA4-mediated ferritinophagy.
Journal: Journal of advanced research
Published: July 08, 2024
Integrated bioinformatics and experimental analysis identify apoptosis- and pyroptosis-related hub genes as candidate diagnostic biomarkers in Alzheimer's disease.
Journal: Journal of applied genetics
Published: July 02, 2024
Uncovering the therapeutic efficacy and mechanisms of Quercetin on traumatic brain injury animals: a meta-analysis and network pharmacology analysis.
Journal: Metabolic brain disease
Published: June 11, 2024
Synthesizing network pharmacology, bioinformatics, and in vitro experimental verification to screen candidate targets of Salidroside for mitigating Alzheimer's disease.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: March 22, 2024
Salidroside Ameliorates Depression by Suppressing NLRP3-Mediated Pyroptosis via P2X7/NF-κB/NLRP3 Signaling Pathway.
Journal: Frontiers in pharmacology
Published: November 10, 2021
Salidroside Ameliorates Alzheimer's Disease by Targeting NLRP3 Inflammasome-Mediated Pyroptosis.
Journal: Frontiers in aging neuroscience
Published: November 05, 2021
Last Updated: 09/26/2026